MedPath

Bolt Metals Corp

Bolt Metals Corp logo
🇺🇸United States
Ownership
Public
Established
2015-01-01
Employees
100
Market Cap
-
Website
http://www.boltbio.com
Introduction

Bolt Metals Corp is engaged in the acquisition and exploration of mineral exploration and evaluation assets in Indonesia. The company owns a nickel project named Cyclops located in Indonesia. It operates in a single reportable operating segment the Acquisition and exploration of exploration and evaluation assets located in Indonesia and Canada.

Cogent Bio Presents Bezuclastinib Data Highlighting Long-Term Benefits in Non-Advanced Systemic Mastocytosis

• Cogent Biosciences will present a poster on bezuclastinib at the AAAAI Annual Meeting, focusing on long-term symptomatic benefits in NonAdvSM patients. • The poster highlights efficacy and safety results from the ongoing SUMMIT trial in adult NonAdvSM patients receiving 100mg of bezuclastinib. • Cogent anticipates top-line results from the SUMMIT trial in July 2025 and plans to submit an NDA for bezuclastinib by the end of 2025. • Expanded Access Programs for bezuclastinib are expected to launch in the U.S. in Q1 2025 for Systemic Mastocytosis and Gastrointestinal Stromal Tumors patients.
© Copyright 2025. All Rights Reserved by MedPath